Biolase Inc Reports Results For The Quarter Ended In June: Earnings Summary

November 26

12/08/2022 04:24

* BIOLASE Inc  BIOL.OQ  reported a quarterly adjusted loss
of 91
cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 62 cents per share.
    * Revenue rose 34% to $12.24 million from a year ago;
analysts
expected $10.63 million. 
    * BIOLASE Inc's reported EPS for the quarter was a loss
of 91
cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.6%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * BIOLASE Inc shares had risen by 15.1% this quarter and
lost 45.9% so far this year.
    * The company reported a quarterly loss of $5.61 million.
    * Wall Street's median 12-month price target for BIOLASE Inc
is
$18.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 12
at 03:24 a.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.62          -0.91          Missed
 Mar. 31 2022      -0.68          -0.81          Missed
 Dec. 31 2021      -0.62          -0.75          Missed
 Sep. 30 2021      -0.69          -0.50          Beat